GLP-1 Digestive Symptom Decision Guide: Bloating, Constipation, Nausea, Gas, and Sulfur Burps

A GLP-1 dose increase can quickly change the digestive picture: a tight belly, three days without a bowel movement, unfamiliar burps, or nausea that raises the question of whether to call a clinician. This guide separates what can usually be managed tonight, what deserves attention this week, and what should never wait until morning while taking semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound).

The Short Answer

Most GLP-1 digestive symptoms trace back to one shared cause: the medication slows how fast food leaves your stomach and moves through your gut. Bloating, constipation, nausea, gas, and sulfur burps are all expected during titration and usually ease as your body adjusts. Severe upper abdominal pain, repeated vomiting, no bowel movement for four days, or new fever or jaundice are not just side effects and need urgent evaluation. WonderBiotics Probiotics for Gut Health was formulated to support digestive comfort and regularity during the kind of gut changes GLP-1 users describe; it is a companion, not a treatment for medication side effects.

Why One Medication Causes Five Different Symptoms

Semaglutide and tirzepatide activate GLP-1 receptors in the gut and the brain. In the gut, this delays gastric emptying, which means food sits in the stomach longer and moves through the small intestine and colon more slowly.¹ That single mechanism drives most of what people describe as their side effects.

• Slower stomach emptying plus satiety and pressure produces the feeling of bloating and early fullness.
• Slower colonic transit produces harder, less frequent bowel movements.
• Brain stem GLP-1 activity combined with slower emptying produces nausea.
• Longer contact between food and bacteria produces more fermentation and more gas.
• More fermentation of sulfur-containing amino acids in food produces hydrogen sulfide, which is the rotten-egg burp.

The frequency numbers, from Wegovy's clinical trials in adults, give a sense of scale. Nausea was reported in 44% of Wegovy-treated patients versus 16% on placebo. Vomiting in 24% versus 6%. Diarrhea in 30% versus 16%. Constipation in 24% versus 11%. Abdominal distension in 7% versus 5%. Eructation, the label term for belching, in 7% versus under 1%.¹ Most of these were reported during dose escalation and eased on maintenance dose.

That last detail matters. Symptoms that begin during the first week or just after a dose increase fit the pattern described on the label. A new digestive change after months on a stable dose sends a different signal.

Bloating: What's Normal, What to Do

Bloating on a GLP-1 has two overlapping sources: food still sitting in your stomach hours after a meal, and gas from slower bacterial fermentation further down. In Wegovy adult trials, 7% of patients reported abdominal distension versus 5% on placebo.¹ That is not a huge statistical signal, but it feels bigger than the number suggests when it is your belly at 9 p.m.

What tends to help:

• Eat smaller portions and stop before you feel full. GLP-1s change how much your stomach can comfortably hold. Old portion sizes now overload it.
• Choose slower-fermenting foods for a stretch. Lean protein, cooked non-cruciferous vegetables, rice, and oats produce less gas than beans, raw broccoli, cauliflower, cabbage, and heavily fibrous salads during the first weeks of a new dose.
• Time your last meal earlier. Because emptying is slow, eating within two hours of bed often means going to sleep with a full stomach.
• Walk after meals. Even ten minutes helps.
• Stay hydrated. Water helps everything downstream move.

If distension is progressive, painful rather than uncomfortable, or accompanied by no bowel movement or gas passing at all, that is not bloating. That is a reason to call your clinician the same day. Ileus has been reported in postmarketing use of semaglutide.¹

Constipation: Getting Things Moving Safely

Constipation was reported in 24% of Wegovy adult patients versus 11% on placebo.¹ A separate real-world analysis of GLP-1 receptor agonist users in the National Institutes of Health All of Us cohort found constipation in 30.4% of users across the class.² The common thread is slower colonic transit combined with eating and drinking less than usual.

A sensible order to try things in:

1. Fluids first. Aim for pale yellow urine as a rough target. Many people cut fluid intake without meaning to when appetite drops.
2. Add soluble fiber gradually. Psyllium is the best-studied option. Start at half a serving and build up over a week. Adding fiber too fast on top of slow transit can make bloating worse before it helps.
3. Move. A daily walk of 20 to 30 minutes reliably improves stool frequency in most people.
4. Magnesium citrate at low doses, typically 200 to 400 mg at night, is a common over-the-counter option many clinicians suggest for medication-related constipation. Check with your prescriber first, especially if you have kidney disease.
5. Osmotic laxatives such as polyethylene glycol (Miralax) are generally considered safer for regular use than stimulant laxatives. Again, ask your prescriber.
6. Probiotic support. Bifidobacterium animalis subsp. lactis HN019 has been studied specifically for constipation. In a 28-day randomized, placebo-controlled trial in 228 adults with functional constipation, HN019 shortened colonic transit time and improved symptom scores compared to placebo.³ Note that this trial was not conducted in GLP-1 medication users.

Four days without a bowel movement, or an inability to pass both stool and gas, is a reason to stop home management and call a clinician. Severe constipation and fecal impaction appear on Wegovy's postmarketing adverse reaction list.¹

Nausea: When It's Titration, When It's Not

Nausea is the most common GLP-1 side effect and the one most likely to make people stop the medication.¹ Typical GLP-1 nausea comes in waves, is triggered by specific foods (especially fatty, fried, or very sweet meals), and tends to sit at the same level for a few days after a dose increase and then fade.

What usually helps:

• Smaller, more frequent meals instead of three large ones
• Bland, low-fat food during a bad stretch: crackers, toast, rice, broth
• Cool or room-temperature food and drinks, which often sit better than hot
• Ginger, as tea or in candied form
• Skipping alcohol during titration
• Sitting upright for at least 30 minutes after eating, not lying down

Ask your prescriber about slowing the titration schedule if nausea is severe. Wegovy's label specifically permits delaying dose escalation by four weeks if a dose is not tolerated.¹

Nausea that behaves differently deserves attention. Relentless rather than wave-like nausea, especially with severe upper abdominal pain that may radiate to the back, follows a pancreatitis pattern and warrants urgent evaluation.¹ Vomiting that stops you from keeping fluids down for more than 24 hours puts you at risk of dehydration and, in some cases, acute kidney injury, which is noted in the label's warnings.¹

Gas and Flatulence: Fermentation on a Slower Clock

Gas gets a smaller headline than nausea but shows up in the same trials. Flatulence was reported in 6% of Wegovy adult patients versus 4% on placebo.¹ The mechanism is straightforward. Slower transit gives colonic bacteria more time to ferment carbohydrates and fiber, and the byproduct is gas.

If gas is your main complaint:

• Reduce the biggest fermentable-carbohydrate offenders temporarily. Beans, lentils, onions, garlic, wheat products in large amounts, and sugar alcohols in "keto" or protein bars (sorbitol, mannitol, xylitol) are usual suspects.
• Chew slowly with your mouth closed. Swallowed air is a real contributor.
• Skip carbonated drinks.
• Simethicone (Gas-X) is safe for occasional use and breaks up gas bubbles mechanically.

Gas on its own is uncomfortable, not dangerous. Gas plus escalating abdominal pain plus vomiting plus no bowel movement is a different picture and needs medical evaluation.

Sulfur Burps: The Rotten-Egg Problem

Sulfur burps are the side effect people are the most embarrassed to Google. They happen because bacteria in the upper gut break down sulfur-containing amino acids (mainly cysteine and methionine, which are concentrated in eggs, red meat, dairy, and cruciferous vegetables) into hydrogen sulfide gas.⁴ Under normal digestion, food moves through fast enough that hydrogen sulfide production stays modest. On a GLP-1, food sits longer in one place, and bacteria have more time to make more of it.

Sulfur burps specifically are not called out by name in FDA labeling, but the parent category, eructation, was reported in 7% of Wegovy-treated adults versus under 1% on placebo.¹ Most people notice it worst in the first days after a dose increase and less so on maintenance.

What helps:

• Eat fewer sulfur-heavy foods for a stretch: eggs, cruciferous vegetables, dairy, and large portions of red meat.
• Eat smaller meals so less protein sits in your stomach at once.
• Simethicone for the bubbles.
• Bismuth subsalicylate (Pepto-Bismol) binds hydrogen sulfide directly and is often the fastest reliever. It should not be used long term or in people who cannot take aspirin.
• Time the worst-offending meals earlier in the day so you are not tasting them at 3 a.m.

Sulfur burps are unpleasant, not dangerous. They almost always fade as titration finishes.

Red Flags: When to Stop Managing and Call

Most GLP-1 digestive symptoms improve on their own or with the strategies above. A smaller number of situations should push you past "how do I fix this" and into "who do I call and how fast." The following categories are drawn from Wegovy's Warnings and Precautions section and its postmarketing reports.¹

Uncertainty about whether a symptom crosses the line is itself a reasonable reason to call the prescribing clinician's nurse line. That is what those lines are for.

Where a Probiotic Fits, and Where It Doesn't

A probiotic is not a treatment for GLP-1 side effects, and no probiotic product, including ours, has been clinically tested in GLP-1 medication users. What the ingredient-level evidence supports is gut comfort and regularity in the general adult population.

WonderBiotics Probiotics for Gut Health includes a primary strain studied for the symptom pattern many GLP-1 users describe. Bifidobacterium animalis subsp. lactis HN019 was tested in a 14-day randomized, triple-blind trial in 100 adults with functional GI symptoms. The high-dose group's whole gut transit time dropped from 49 hours to 21 hours, and eight of nine tracked symptoms, including bloating, gas, nausea, and vomiting, decreased in frequency.⁵ A separate 28-day randomized, placebo-controlled trial in 228 adults with functional constipation showed that HN019 shortened colonic transit and improved symptom scores versus placebo.³ The WonderBiotics formula pairs HN019 with Lactobacillus acidophilus NCFM, another well-characterized strain studied for digestive comfort, plus 10 additional strains and a multi-enzyme complex.

Neither HN019 trial enrolled people taking semaglutide or tirzepatide. WonderBiotics treats that as a real evidence limit. The defensible conclusion is that HN019 targets bowel regularity and digestive comfort, two functional outcomes that GLP-1 users often struggle with, and has a documented safety profile in generally healthy adults.

A few practical points matter when adding a probiotic to a GLP-1 routine:

• Talk with your prescribing clinician first, especially if you are immunocompromised, seriously ill, post-surgical, or on cancer treatment. Live bacterial supplements carry a different risk profile in those situations.
• Give it time. Probiotic effects on transit and comfort typically show up over weeks, not days.
• A probiotic will not fix a severe side effect and should never replace calling your clinician about a red flag.
• Take it consistently, at the same time each day and with food if that is what the label directs.

Talking to Your Prescribing Clinician

Clear, early symptom descriptions make it easier for the care team to respond and may help prevent avoidable interruptions. Useful phrasing for a nurse call or portal message includes:

• "I'm on [medication and dose]. I moved up to this dose on [date]. Since then I have had [symptom] that is [mild, moderate, or severe] and [improving, stable, or worsening]."
• "I've tried [specific strategies], and here is what happened."
• "I want to ask about [slowing the titration, staying at this dose longer, dietary options, or a prescription anti-nausea option]."

This is faster than describing symptoms in general terms and usually gets a clearer answer back.

A Note on Medical Care

This article is for general information about digestive symptoms during GLP-1 therapy. It is not medical advice, does not diagnose or treat any condition, and does not replace guidance from your prescribing clinician. Live probiotic supplements are generally well tolerated in healthy adults but carry different risks for people who are immunocompromised, seriously ill, or post-surgical. If you have any of the red-flag symptoms above, or you are unsure whether a symptom is safe to manage at home, contact your clinician or seek emergency care.

References

1. WEGOVY (semaglutide) injection prescribing information. Novo Nordisk. Revised August 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s024lbl.pdf
2. Baber MU, Zaidi S, Ahmad A, et al. Glucagon-like peptide-1 receptor agonists associated gastrointestinal adverse events: a cross-sectional analysis of the National Institutes of Health All of Us cohort. Pharmaceuticals. 2024;17(2):199. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10891568/
3. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: a double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes. 2018;9(3):236-251. https://www.tandfonline.com/doi/full/10.1080/19490976.2017.1412908
4. Blachier F, Beaumont M, Kim E. Cysteine-derived hydrogen sulfide and gut health: a matter of endogenous or bacterial origin. Curr Opin Clin Nutr Metab Care. 2019;22(1):68-75. https://pubmed.ncbi.nlm.nih.gov/30461448/
5. Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011;46(9):1057-1064. https://pubmed.ncbi.nlm.nih.gov/21663486/